Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 5:46 pm Purchase | 13G | RxSight Inc. RXST | RA CAPITAL MANAGEMENT L.P. | 3,916,825 9.900% | 512,540 (+15.06%) | View |
| 2024-11-12 4:50 pm Unchanged | 13G | RxSight Inc. RXST | VANGUARD GROUP INC | 2,287,084 5.760% | 0 (Unchanged) | View |
| 2024-11-12 09:40 am Sale | 13G | RxSight Inc. RXST | Artisan Partners Limited Partnership | 1,170,231 2.900% | -1,225,441 (-51.15%) | View |
| 2024-11-08 2:17 pm Unchanged | 13G | RxSight Inc. RXST | BlackRock Inc. BLK | 2,787,308 7.000% | 0 (Unchanged) | View |
| 2024-11-04 1:52 pm Purchase | 13G | RxSight Inc. RXST | VANGUARD GROUP INC | 2,287,084 5.760% | 2,287,084 (New Position) | View |
| 2024-10-22 6:06 pm Purchase | 13G | RxSight Inc. RXST | BlackRock Inc. BLK | 2,787,308 7.000% | 710,838 (+34.23%) | View |
| 2024-02-14 5:01 pm Purchase | 13G | RxSight Inc. RXST | RA CAPITAL MANAGEMENT L.P. | 3,404,285 9.500% | 351,489 (+11.51%) | View |
| 2024-02-14 07:54 am Purchase | 13G | RxSight Inc. RXST | LORD ABBETT & CO. LLC | 1,977,000 5.510% | 1,977,000 (New Position) | View |
| 2024-02-12 06:19 am Purchase | 13G | RxSight Inc. RXST | Artisan Partners Limited Partnership | 2,395,672 6.700% | 2,395,672 (New Position) | View |
| 2024-01-29 5:25 pm Purchase | 13G | RxSight Inc. RXST | BlackRock Inc. BLK | 2,076,470 5.800% | 2,076,470 (New Position) | View |
| 2023-08-18 4:18 pm Sale | 13D | RxSight Inc. RXST | Longitude Capital Partners II LLC | 1,774,559 5.000% | -764,478 (-30.11%) | View |
| 2023-06-05 4:52 pm Purchase | 13D | RxSight Inc. RXST | Longitude Capital Partners II LLC | 2,539,037 7.500% | 32,065 (+1.28%) | View |
| 2023-02-14 4:55 pm Sale | 13G | RxSight Inc. RXST | ORBIMED ADVISORS LLC | 923,733 3.300% | -138,767 (-13.06%) | View |
| 2022-02-14 5:06 pm Purchase | 13G | RxSight Inc. RXST | RxSight I LLC | 2,016,778 7.600% | 2,016,778 (New Position) | View |
| 2022-02-14 3:53 pm Purchase | 13G | RxSight Inc. RXST | TAMER ANTHONY | 2,010,037 7.340% | 2,010,037 (New Position) | View |
| 2022-02-14 2:40 pm Purchase | 13G | RxSight Inc. RXST | Wolfen Richard M. | 1,827,349 6.700% | 1,827,349 (New Position) | View |
| 2022-02-11 4:42 pm Purchase | 13G | RxSight Inc. RXST | ORBIMED ADVISORS LLC | 1,062,500 3.900% | 1,062,500 (New Position) | View |
| 2021-08-13 5:15 pm Purchase | 13D | RxSight Inc. RXST | Longitude Capital Partners II LLC | 2,506,972 9.100% | 2,506,972 (New Position) | View |
| 2021-08-13 4:30 pm Purchase | 13G | RxSight Inc. RXST | RA CAPITAL MANAGEMENT L.P. | 3,052,796 11.100% | 3,052,796 (New Position) | View |